Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name KITE-363
Trade Name
Synonyms KITE 363|KITE363
Drug Descriptions

KITE-363 comprises autologous T-lymphocytes engineered to express chimeric antigen receptors (CARs) targeting CD19 and CD20 as well as the CD28 and 4-1BB costimulatory domains, which potentially results in killing of tumor cells expressing CD19 and/or CD20 (J Clin Oncol 40, no. 16_suppl (June 01, 2022) TPS7579).

CAS Registry Number NA
NCIT ID C181943


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Cyclophosphamide + Fludarabine + KITE-363 Cyclophosphamide Fludarabine KITE-363 0 1
KITE-363 KITE-363 0 0

Additional content available in CKB BOOST